Crossmark

Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway

Published Online: 2023-05-24

Published Print: 2023-10

Authors

Zou, Ting-feng

Liu, Zhi-gang

Cao, Pei-chang

Zheng, Shi-hong

Guo, Wen-tong

Wang, Tian-xiang

Chen, Yuan-li

Duan, Ya-jun

Li, Qing-shan

Liao, Chen-zhong

Xie, Zhou-ling

Han, Ji-hong

Yang, Xiao-xiao
License Information

Text and Data Mining valid from 2023-05-24

Version of Record valid from 2023-05-24
More Information

Article History

Received: 8 December 2022

Accepted: 7 May 2023

First Online: 24 May 2023

Competing interests

: The authors declare no competing interests.

Document is current